FDA Staff Weighs in on Tanning Bed Skin Cancer Risk

Just days before an advisory committee meeting is scheduled to discuss regulation of tanning beds, the FDA has released a report pointing out that there is growing evidence that tanning beds cause skin cancer

The tanning bed report (pdf) was released by the FDA on Tuesday, providing background information to the FDA’s General and Plastic Surgery Devices Panel, a subcommittee of the Medical Devices Advisory Committee. The panel will meet in a public hearing on Friday to discuss tanning bed regulation concerns that have arisen in the wake of a World Health Organization (WHO) decision to reclassify tanning beds as known carcinogens last year.

“There continues to be a growing body of literature showing association of skin cancer with use of tanning lamps and the committee will discuss this information and other information related to the association of UV and skin cancer,” the report states.

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

One of the studies was by WHO itself in July 2009. WHO’s report determined that the use of tanning beds before the age of 30 increases the risk of skin cancer by 75%. As a result of the study, WHO reclassified ultraviolet radiation from tanning beds and other sources as a definite carcinogen. Previously, they were considered “probable” carcinogens.

Some studies have shown that the use of tanning beds by young adults results in eight times the risk of developing melanoma, a deadly form of skin cancer once found mainly in the elderly, but which has increasingly become a problem for younger adults. The American Cancer Society says that melanoma, the most dangerous form of skin cancer, is diagnosed in about 69,000 Americans each year and causes about 8,650 deaths annually. Less dangerous, but more common, basal and squamous cell carcinomas affect more than one million Americans each year and cause about 2,000 deaths annually.

The FDA’s report notes that the tanning industry has grown rapidly over the last two decades. The agency estimates that each year at least 30 million Americans visit one of the nation’s 25,000 indoor tanning businesses.

The report states that a growing number of children are counted among the ranks of tanning bed users, with nearly 10% going to indoor tanning businesses in 1999. The report also expresses concerns by some researchers that as many as 95% of indoor tanning customers are exceeding the recommended safe time in tanning beds.

Concerns over tanning bed cancer has resulted in bipartisan legislation aimed at lowering tanning bed cancer risks. The Tanning Bed Cancer Control Act, was introduced in late January by U.S. Representatives Carolyn Maloney (D-New York) and Charlie Dent (R-Pennsylvania). The bill would allow federal regulators to set controls on the amount of ultraviolet radiation emitted by tanning beds as well as set limits on the amount of time users can use the devices.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025
Lawyers Propose MDL Trial Dates for Baby Formula NEC Lawsuit Starting in May 2025 (Posted yesterday)

A series of four bellwether claims in the baby formula NEC lawsuit MDL will be ready to go before a federal juries in May 2025, August 2025, November 2025 and February 2026 according to a proposed trial schedule agreed upon by both plaintiffs and defendants.

AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California
AngioDynamics Port Catheter Lawsuit MDL Established in Southern District of California (Posted 2 days ago)

U.S. JPML has transferred all AngioDynamics port catheter lawsuits to the U.S. District Court for the Southern District of California, for coordinated discovery and pretrial proceedings as part of a federal MDL (multidistrict litigation).